IBM and IDBS Align for Chem-Bio Integration
IBM and IDBS announced a global strategic alliance last week focused around the development of an informatics platform to integrate chemical and biological data.
The companies will jointly market and sell IDBS software optimized for IBM systems. This includes the company’s ActivityBase software for integrating biological and chemical drug discovery data; DiscoveryChannel, a web-based data-mining application; and Discovery Warehouse for data consolidation. IDBS has optimized its software for IBM eServer pSeries systems running AIX, DB2, DiscoveryLink, and WebSphere.
Biotique Expands Internationally
Biotique Systems last week said that it has signed an exclusive marketing and distribution agreement for its complete product line with Tomy Digital Biology in Japan, and has also opened a new European office in Basel, Switzerland.
Gene Logic Closes TherImmune Acquisition
Gene Logic announced the completion of its acquisition of TherImmune Research on April 2.
Gene Logic paid approximately $30.9 million in cash and issued 3,978,615 shares of common stock, with a value of approximately $21.1 million.
BioWisdom Closes $3.9M in Financing
Cambridge, UK-based ontology software provider BioWisdom has completed a round of equity financing totaling £2.5 million ($3.9 million).
The investment was led by Merlin Biosciences and included MB Venture Capital Fund I. Several members of the company’s management team and founders also participated in the round. BioWisdom has raised a total of £4.6 million ($7.1 million) since it was incorporated in 2000.
Mark Docherty, investment director of Merlin Biosciences, has taken a seat on the company’s board.